What does the pancreas do

Pancreas Anatomy and Location

The pancreas is a soft, pale gray glandular organ measuring approximately 6 inches (15 centimeters) in length and weighing about 1.4 ounces (40 grams). Located in the retroperitoneal space behind the stomach, between the left kidney and the spleen, the pancreas is not easily palpable during physical examinations. The organ consists of a head (positioned within the C-curve of the duodenum), a body (the central portion), and a tail (extending toward the spleen). The main pancreatic duct runs through the center of the organ and merges with the common bile duct from the liver before emptying into the duodenum at the ampulla of Vater.

Despite its small size and hidden location, the pancreas performs essential functions through two distinct tissue types: exocrine tissue (approximately 95% of the organ) that produces digestive enzymes, and endocrine tissue (approximately 5%) organized into islands of Langerhans that produce hormones. Blood supply to the pancreas comes from the superior and inferior pancreaticoduodenal arteries and the splenic artery, while venous drainage feeds into the portal vein system. The pancreas's dual function and complex vascular architecture make it vulnerable to various pathological conditions when its structure or blood supply becomes compromised.

Exocrine Function: Enzyme Production for Digestion

The exocrine pancreas produces approximately 1.5 to 2 liters of pancreatic juice daily, containing more than 22 different enzymes essential for breaking down all macronutrients. These enzymes include proteases (trypsin, chymotrypsin, carboxypeptidases) that digest proteins into amino acids, lipases that break down fats into fatty acids and glycerol, and amylases that digest carbohydrates into simple sugars. The pancreatic juice also contains sodium bicarbonate, which neutralizes acidic chyme (partially digested food) entering from the stomach, raising the pH in the small intestine to approximately 8, the optimal environment for intestinal enzyme function.

When food enters the duodenum, the hormone cholecystokinin (CCK) triggers the pancreas to release enzyme-rich pancreatic juice through the main pancreatic duct into the small intestine. The hormone secretin stimulates bicarbonate-rich pancreatic juice release to neutralize stomach acid. These hormonal signals allow the pancreas to precisely match enzyme secretion to the composition and quantity of food entering the digestive tract. Approximately 40% to 50% of the protein-digesting enzymes in the small intestine originate from pancreatic secretion, making the pancreas essential for efficient protein digestion and amino acid absorption.

The quality of protein digestion depends critically on pancreatic enzyme production. When the pancreas fails to produce adequate enzymes, a condition called pancreatic insufficiency, protein malabsorption occurs. This results in steatorrhea (fatty stools), reduced absorption of fat-soluble vitamins (A, D, E, K), and nutritional deficiencies. Pancreatic lipase deficiency particularly affects fat absorption, as pancreatic lipase is responsible for breaking down approximately 90% of dietary triglycerides. Without sufficient pancreatic lipase, patients experience severe fat malabsorption and require pancreatic enzyme replacement therapy.

Endocrine Function: Hormone Production and Blood Glucose Regulation

The endocrine pancreas, comprising approximately 1 to 2 million islet clusters (islands of Langerhans) distributed throughout the organ, produces hormones critical for glucose metabolism and energy regulation. Beta cells, comprising approximately 70% of islet cells, produce insulin, which lowers blood glucose by facilitating glucose uptake into muscle and fat cells and promoting glucose storage as glycogen in the liver. In healthy individuals, fasting blood glucose levels are maintained between 70 and 100 mg/dL through insulin secretion; this concentration increases to 140-180 mg/dL postprandially (after meals) before insulin brings levels back down within 2-3 hours.

Alpha cells, comprising approximately 20% of islet cells, produce glucagon, which raises blood glucose by stimulating glycogen breakdown in the liver and promoting glucose synthesis from non-carbohydrate sources (gluconeogenesis). Delta cells produce somatostatin, which inhibits both insulin and glucagon secretion, providing fine-tuned regulation of hormone balance. This sophisticated feedback system maintains blood glucose within a narrow range despite varying dietary intake, physical activity, and hormonal influences. When pancreatic beta cells are damaged or destroyed, as in Type 1 diabetes where approximately 90% of beta cells are lost to autoimmune destruction, insulin production ceases and blood glucose control is lost without exogenous insulin therapy.

Type 2 diabetes represents a different pancreatic dysfunction: beta cells continue producing insulin, but peripheral tissues (muscle and fat) develop insulin resistance, requiring the pancreas to produce increasingly large amounts of insulin to maintain blood glucose control. Over time, this excessive demand exhausts beta cell function, and insulin production eventually declines. The American Diabetes Association estimates that Type 2 diabetes affects approximately 37.3 million Americans, representing approximately 11.3% of the total population, highlighting the critical importance of pancreatic function in population health.

Common Misconceptions and Medical Considerations

A widespread misconception is that the pancreas's primary function is blood sugar regulation; in reality, digestion represents its more crucial exocrine function, consuming the majority of the organ's tissue. Many people assume pancreatic problems manifest solely as diabetes; in fact, pancreatic cancer, pancreatitis, and pancreatic insufficiency represent distinct pathological conditions with different etiologies and outcomes. Pancreatic cancer, diagnosed in approximately 63,000 Americans annually, has one of the lowest survival rates of any cancer because the pancreas's hidden location delays diagnosis until advanced stages.

Another common misunderstanding is that Type 1 and Type 2 diabetes represent the same disease with different severity levels. In reality, they involve fundamentally different pancreatic dysfunction: Type 1 results from autoimmune destruction of beta cells with absent insulin production, while Type 2 involves insulin resistance with eventual beta cell exhaustion. This distinction is critical for treatment, as Type 1 diabetes absolutely requires exogenous insulin therapy, while Type 2 may initially respond to lifestyle modifications, oral medications that enhance insulin secretion or sensitivity, or insulin injections if needed later.

Some individuals believe the pancreas can be completely removed without significant consequences. While surgical pancreatectomy is occasionally necessary for cancer treatment, removal necessitates lifelong enzyme replacement therapy to manage digestion and multiple daily insulin injections to manage blood glucose. Pancreatic transplantation has been performed since 1966, with current 5-year graft survival rates approximately 60% for living donor transplants and 50% for deceased donor transplants, demonstrating the pancreas's irreplaceable importance despite transplantation's modest success rates.

Age-Related Changes and Long-Term Pancreatic Health

Pancreatic function declines gradually with age, beginning around age 30 when enzyme secretion starts diminishing. By age 70, some individuals exhibit reduced pancreatic enzyme output of approximately 30% compared to younger adults, though this variation is significant among individuals. This age-related decline may contribute to reduced protein digestion efficiency and altered nutrient absorption in older adults. Additionally, pancreatic weight decreases from approximately 40 grams at age 20 to 30 grams at age 80, with increased fatty infiltration replacing functional acinar tissue.

Certain lifestyle factors significantly impact long-term pancreatic health. Chronic alcohol consumption damages pancreatic acinar cells, causing chronic pancreatitis characterized by inflammation, fibrosis, and eventual loss of exocrine function. Approximately 60-70% of chronic pancreatitis cases in developed countries result from chronic alcohol abuse. Smoking increases pancreatic cancer risk by approximately 75% compared to never-smokers and is associated with accelerated pancreatic aging. High-fat diets and obesity increase the risk of acute pancreatitis, where pancreatic enzymes prematurely activate within the pancreas itself, causing self-digestion and inflammation. Maintaining healthy weight, limiting alcohol, avoiding smoking, and managing blood glucose through diet and exercise represent evidence-based approaches to preserving pancreatic function throughout life.